{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:57:19Z","timestamp":1770897439843,"version":"3.50.1"},"reference-count":122,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1210\/jc.2017-01991","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T19:07:30Z","timestamp":1517512050000},"page":"1779-1789","source":"Crossref","is-referenced-by-count":10,"title":["Pheochromocytoma\/Paraganglioma: A Poster Child for Cancer Metabolism"],"prefix":"10.1210","volume":"103","author":[{"given":"Sergei G","family":"Tevosian","sequence":"first","affiliation":[{"name":"Department of Physiological Sciences, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans K","family":"Ghayee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of Florida, Gainesville, Florida"},{"name":"Malcom Randall VA Medical Center, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"13","key":"key\n\t\t\t\t20180507140033_B1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa071407","article-title":"Evidence of MEN-2 in the original description of classic pheochromocytoma","volume":"357","author":"Neumann","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180507140033_B2","first-page":"16","article-title":"Das Ganglioma embryonale sympathicum (Sympathoma embryonale), eine typische b\u00f6sartige Geschwulstform des sympathischen Nervensystems","volume":"49","author":"Pick","year":"1912","journal-title":"Berlin Klin Wochenschr"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF03346390","article-title":"The many faces of pheochromocytoma","volume":"31","author":"Ghayee","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","article-title":"Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism","volume":"4","author":"Otto","year":"2016","journal-title":"Cancer Metab"},{"issue":"5454","key":"key\n\t\t\t\t20180507140033_B5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"key\n\t\t\t\t20180507140033_B8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tem.2017.08.001","article-title":"New insights into the nuclear imaging phenotypes of cluster 1 pheochromocytoma and paraganglioma","volume":"28","author":"Ta\u00efeb","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20180507140033_B10","doi-asserted-by":"crossref","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg effect is genetically determined in inherited pheochromocytomas","volume":"4","author":"Favier","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B11","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision medicine: an update on genotype-biochemical phenotype relationships in pheochromocytoma\/paraganglioma patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B13","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cancergen.2016.04.058","article-title":"ATRX driver mutation in a composite malignant pheochromocytoma","volume":"209","author":"Comino-M\u00e9ndez","year":"2016","journal-title":"Cancer Genet"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"9","key":"key\n\t\t\t\t20180507140033_B16","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"key\n\t\t\t\t20180507140033_B18","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMc1211953","article-title":"HIF2A mutations in paraganglioma with polycythemia","volume":"367","author":"Favier","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B19","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-M\u00e9ndez","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"7","key":"key\n\t\t\t\t20180507140033_B20","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Crona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","article-title":"Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas","volume":"95","author":"Gaal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B22","doi-asserted-by":"crossref","first-page":"L57","DOI":"10.1530\/ERC-17-0061","article-title":"KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors","volume":"24","author":"Evenepoel","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"key\n\t\t\t\t20180507140033_B23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B24","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Cascon","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B25","first-page":"1595","article-title":"The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas","volume":"5","author":"Santoro","year":"1990","journal-title":"Oncogene"},{"issue":"6428","key":"key\n\t\t\t\t20180507140033_B26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180507140033_B27","first-page":"33","article-title":"Malignancy in neurofibromatosis","volume":"29","author":"Hope","year":"1981","journal-title":"Adv Neurol"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"25","key":"key\n\t\t\t\t20180507140033_B30","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"key\n\t\t\t\t20180507140033_B31","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"key\n\t\t\t\t20180507140033_B32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"issue":"14","key":"key\n\t\t\t\t20180507140033_B36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.1995.03530140061033","article-title":"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II","volume":"274","author":"Neumann","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"key\n\t\t\t\t20180507140033_B38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"issue":"20","key":"key\n\t\t\t\t20180507140033_B40","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B42","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/10409238.2014.990556","article-title":"Protein-mediated assembly of succinate dehydrogenase and its cofactors","volume":"50","author":"Van Vranken","year":"2015","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B46","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1371\/journal.pone.0000436","article-title":"A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia","volume":"2","author":"Baysal","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","article-title":"The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications","volume":"266","author":"Stratakis","year":"2009","journal-title":"J Intern Med"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10048-011-0280-y","article-title":"Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma\/pheochromocytoma (PGL\/PCC)","volume":"12","author":"M\u00fcller","year":"2011","journal-title":"Neurogenetics"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B51","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","article-title":"SDH mutations in cancer","volume":"1807","author":"Bardella","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180507140033_B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-7-1","article-title":"Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and\/or pheochromocytoma","volume":"7","author":"Bayley","year":"2006","journal-title":"BMC Med Genet"},{"issue":"9","key":"key\n\t\t\t\t20180507140033_B53","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.onc.1206300","article-title":"Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas","volume":"22","author":"Benn","year":"2003","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B54","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/324413","article-title":"The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway","volume":"69","author":"Gimenez-Roqueplo","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B55","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations","volume":"143","author":"Jochmanova","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"5944","key":"key\n\t\t\t\t20180507140033_B57","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1471-2407-12-408","article-title":"SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors","volume":"12","author":"Italiano","year":"2012","journal-title":"BMC Cancer"},{"issue":"9","key":"key\n\t\t\t\t20180507140033_B59","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol"},{"key":"key\n\t\t\t\t20180507140033_B60","volume-title":"Hereditary paraganglioma-pheochromocytoma syndromes","author":"Klein","year":"2009"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B61","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ncb3233","article-title":"Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis","volume":"17","author":"Cardaci","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B62","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/ncomms9784","article-title":"Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism","volume":"6","author":"Lussey-Lepoutre","year":"2015","journal-title":"Nat Commun"},{"issue":"21","key":"key\n\t\t\t\t20180507140033_B63","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/hmg\/ddi359","article-title":"Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions","volume":"14","author":"Bri\u00e8re","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1097-0347(199808)20:5<374::AID-HED3>3.0.CO;2-V","article-title":"Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level","volume":"20","author":"Rodr\u00edguez-Cuevas","year":"1998","journal-title":"Head Neck"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00439-003-0969-6","article-title":"Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect","volume":"113","author":"Astrom","year":"2003","journal-title":"Hum Genet"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B66","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driven tumorigenesis: from genetics to targeted therapy","volume":"135","author":"Morin","year":"2014","journal-title":"Int J Cancer"},{"issue":"15","key":"key\n\t\t\t\t20180507140033_B67","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccr.2013.05.015","article-title":"Succinate: a new epigenetic hacker","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biochi.2005.07.011","article-title":"Differential responses of two degradation domains of HIF-1alpha to hypoxia and iron deficiency","volume":"88","author":"Lee","year":"2006","journal-title":"Biochimie"},{"issue":"24","key":"key\n\t\t\t\t20180507140033_B71","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1737","article-title":"Mitochondrial tumour suppressors: a genetic and biochemical update","volume":"5","author":"Gottlieb","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"33","key":"key\n\t\t\t\t20180507140033_B74","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B75","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.01338-07","article-title":"Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis","volume":"28","author":"Guzy","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/0008-5472.203.65.1","article-title":"A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis","volume":"65","author":"Ishii","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B77","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.gde.2010.02.008","article-title":"Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree","volume":"20","author":"Bayley","year":"2010","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1210\/jc.2008-1836","article-title":"Rationale and evidence for sunitinib in the treatment of malignant paraganglioma\/pheochromocytoma","volume":"94","author":"Joshua","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2008-1972","article-title":"Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors","volume":"94","author":"Jimenez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180507140033_B80","unstructured":"ClinicalTrials.gov . Genetic analysis of pheochromocytomas, paragangliomas and associated conditions. ClinicalTrials.gov identifier: NCT03160274. Registered 19 October 2005. Updated 19 May 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03160274."},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B81","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2011-3437","article-title":"Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations","volume":"97","author":"Loriot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B82","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2967\/jnumed.114.137034","article-title":"Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma","volume":"55","author":"van Berkel","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B84","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"issue":"5897","key":"key\n\t\t\t\t20180507140033_B85","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"7274","key":"key\n\t\t\t\t20180507140033_B86","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"116","key":"key\n\t\t\t\t20180507140033_B87","doi-asserted-by":"crossref","first-page":"116ra4","DOI":"10.1126\/scitranslmed.3002693","article-title":"Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy","volume":"4","author":"Andronesi","year":"2012","journal-title":"Sci Transl Med"},{"issue":"4","key":"key\n\t\t\t\t20180507140033_B88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B89","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J Exp Med"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-011-0737-8","article-title":"Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy","volume":"107","author":"Pope","year":"2012","journal-title":"J Neurooncol"},{"issue":"7390","key":"key\n\t\t\t\t20180507140033_B91","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"5924","key":"key\n\t\t\t\t20180507140033_B93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B94","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B95","doi-asserted-by":"crossref","first-page":"e16812","DOI":"10.1371\/journal.pone.0016812","article-title":"2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations","volume":"6","author":"Jin","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B96","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11060-011-0625-2","article-title":"IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients","volume":"105","author":"Metellus","year":"2011","journal-title":"J Neurooncol"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B97","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-010-0790-y","article-title":"R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1\u03b1 upregulation in adult glioma","volume":"121","author":"Williams","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B98","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2016.09.015","article-title":"Mitochondrial protein lipoylation and the 2-oxoglutarate dehydrogenase complex controls HIF1\u03b1 stability in aerobic conditions","volume":"24","author":"Burr","year":"2016","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180507140033_B99","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1038\/srep18928","article-title":"Oxidative dimerization of PHD2 is responsible for its inactivation and contributes to metabolic reprogramming via HIF-1\u03b1 activation","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"7390","key":"key\n\t\t\t\t20180507140033_B101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B102","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.clml.2016.04.006","article-title":"Evidence for clinical differentiation and differentiation syndrome in patients with acute myeloid leukemia and IDH1 mutations treated with the targeted mutant IDH1 inhibitor, AG-120","volume":"16","author":"Birendra","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"key\n\t\t\t\t20180507140033_B103","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/leu.2017.84","article-title":"A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML","volume":"31","author":"Kats","year":"2017","journal-title":"Leukemia"},{"issue":"2-3","key":"key\n\t\t\t\t20180507140033_B104","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.beha.2015.10.016","article-title":"IDH2 inhibition in AML: finally progress","volume":"28","author":"Stein","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/1531-8249(200005)47:5<583::AID-ANA5>3.0.CO;2-Y","article-title":"Fumaric aciduria: clinical and imaging features","volume":"47","author":"Kerrigan","year":"2000","journal-title":"Ann Neurol"},{"issue":"4","key":"key\n\t\t\t\t20180507140033_B106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00109-011-0728-4","article-title":"Inborn and acquired metabolic defects in cancer","volume":"89","author":"Frezza","year":"2011","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000345608","article-title":"Downregulation of fumarate hydratase is related to tumorigenesis in sporadic renal cell cancer","volume":"90","author":"Ha","year":"2013","journal-title":"Urol Int"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B109","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1210\/jc.2006-0183","article-title":"Adult Leydig cell tumors of the testis caused by germline fumarate hydratase mutations","volume":"91","author":"Carvajal-Carmona","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key\n\t\t\t\t20180507140033_B110","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/ijc.26317","article-title":"Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas","volume":"130","author":"Fieuw","year":"2012","journal-title":"Int J Cancer"},{"issue":"10","key":"key\n\t\t\t\t20180507140033_B111","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B112","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10545-011-9294-8","article-title":"Structural basis of fumarate hydratase deficiency","volume":"34","author":"Picaud","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"7363","key":"key\n\t\t\t\t20180507140033_B113","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10363","article-title":"Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","volume":"477","author":"Frezza","year":"2011","journal-title":"Nature"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B114","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.celrep.2013.04.006","article-title":"A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia","volume":"3","author":"Adam","year":"2013","journal-title":"Cell Reports"},{"issue":"1","key":"key\n\t\t\t\t20180507140033_B115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-1-12","article-title":"Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells","volume":"1","author":"Zheng","year":"2013","journal-title":"Cancer Metab"},{"issue":"12","key":"key\n\t\t\t\t20180507140033_B116","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B117","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1074\/jbc.M115.688762","article-title":"Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes","volume":"291","author":"Laukka","year":"2016","journal-title":"J Biol Chem"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20180507140033_B119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"issue":"5","key":"key\n\t\t\t\t20180507140033_B120","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20180507140033_B121","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/MCB.01223-06","article-title":"Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro","volume":"27","author":"Pan","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"8","key":"key\n\t\t\t\t20180507140033_B122","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/carcin\/bgt209","article-title":"HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression","volume":"34","author":"Philip","year":"2013","journal-title":"Carcinogenesis"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/5\/1779\/24795006\/jc.2017-01991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:37:17Z","timestamp":1660419437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/5\/1779\/4834035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":122,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01991","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,2,1]]}}}